Cryptosporidium sporozoite antigens
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 2, 2003
app pub date -
Apr 9, 2003
filing date -
Dec 1, 1999
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Antigenic polypeptides and peptides from Cryptosporidium, and nucleic acid molecules encoding same, are dis-closed which have potential for use in a protective vaccine preparation. A preferred polypeptide has the amino acid sequence, (a).1 10 20 30 40 MRLSLIIVLL SVIVSAVFSA PAVPLRGTLK DVPVEGSSSS 50 60 70 80 SSSSSSSSSS SSSSSSSTST VAPANKARTG EDAEGSQDSS 90 100 110 120 GTEASGSQGS EEEGSEDDGQ TSAASQPTTP AQSEGATTET 130 140 150 160 IEATPKEECG TSFVMWFGEG TPAATLKCGA YTIVYAPIKD 170 180 190 200 QTDPAPRYIS GEVTSVTFEK SDNTVKIKVN GQDFSTLSAR 210 220 230 240 SSSPTENGGS AGQASSRSRR SLSEETSEAA ATVDLFAFTL 250 260 270 280 DGGKRIEVAV PNVEDASKRD KYSLVADDKP FYTGANSGTT 290 300 310 320 NGVYRLNENG DLVDKDNTVL
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully